0001209191-21-051915.txt : 20210817
0001209191-21-051915.hdr.sgml : 20210817
20210817170136
ACCESSION NUMBER: 0001209191-21-051915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210813
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ramakrishnan Ramesh
CENTRAL INDEX KEY: 0001845434
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40047
FILM NUMBER: 211183575
MAIL ADDRESS:
STREET 1: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Talis Biomedical Corp
CENTRAL INDEX KEY: 0001584751
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-433-3000
MAIL ADDRESS:
STREET 1: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SlipChip Corp
DATE OF NAME CHANGE: 20130820
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-13
1
0001584751
Talis Biomedical Corp
TLIS
0001845434
Ramakrishnan Ramesh
C/O TALIS BIOMEDICAL CORPORATION
230 CONSTITUTION DRIVE
MENLO PARK
CA
94025
0
0
0
1
Former Officer
Common Stock
2021-08-13
4
M
0
43614
1.50
A
57380
D
Common Stock
2021-08-13
4
M
0
8741
1.50
A
66121
D
Common Stock
2021-08-13
4
S
0
27502
7.66
D
38619
D
Stock Option (right to buy)
1.50
2021-08-13
4
M
0
43614
0.00
D
2021-08-14
Common Stock
43614
0
D
Stock Option (right to buy)
1.50
2021-08-13
4
M
0
8741
0.00
D
2021-08-14
Common Stock
8471
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.
25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
/s/ J. Roger Moody, Jr., Attorney-in-Fact for Ramesh Ramakrishnan
2021-08-17